超,男,主治醫(yī)師,講師,博士在讀。2003年畢業(yè)于南京醫(yī)科大學(xué)后開(kāi)始從事泌尿外科臨床、教學(xué)和科研工作,熟練掌握泌尿系結(jié)石和腫瘤的微創(chuàng)治療,長(zhǎng)期致力于膀胱腫瘤的基礎(chǔ)和臨床研究,尤其是膀胱癌的個(gè)性化診斷和治療。專(zhuān)業(yè)研究方向?yàn)榘螂装┑幕A(chǔ)、臨床研究及綜合治療。目前主持自然科學(xué)基金青年基金課題1項(xiàng),作為重要成員參與自然科學(xué)基金課題1項(xiàng),省級(jí)課題3項(xiàng)。獲江蘇省衛(wèi)生廳新技術(shù)引進(jìn)二等獎(jiǎng)1項(xiàng),獲發(fā)明專(zhuān)利1項(xiàng)(排名第二),實(shí)用新型專(zhuān)利3項(xiàng)(排名第二)。【科研項(xiàng)目】1.自然科學(xué)基金青年基金:miR-141在6P22擴(kuò)增膀胱移行癌中與E2F3/Rb信號(hào)通路交互調(diào)控機(jī)制的研究2. 自然科學(xué)基金:miR-218在膀胱癌侵襲性中的機(jī)制研究主要參與者3. 江蘇省自然科學(xué)基金 :膀胱癌中靶向miR-21膀胱灌注的基礎(chǔ)研究主要參與者4.江蘇省“科教興衛(wèi)”工程醫(yī)學(xué)核心學(xué)科子課題:雷帕霉素靶向灌注治療高危非肌層浸潤(rùn)性膀胱移行細(xì)胞癌研究主要參與者【成果】1. 江蘇省衛(wèi)生廳新技術(shù)引進(jìn)二等獎(jiǎng):精囊鏡應(yīng)用于精囊疾病的診斷和治療【發(fā)表文章】1. Li P, Song N, Yin C, Zhang W, Li J, Hua L, Wang Z, Cheng G. Glans-Preserving Surgery for Superficial Penile Cancer. J Androl. 2012 May-Jun;33(3):435-40. Epub 2011 Aug 25.2. Xu B, Li P, Niu X, Zhang X, Wang Z, Qin C, Li J, Jia Y, Wu H, Zhang W. A New Method of Chronic and Recurrent Seminal Vesiculitis Treatment. J Endourol. 2011 ,25(11):1815-1818. (并列)3. Feng Ninghan. Xu Bin. Tao Jun. Li Pengchao et al. A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China. Mol Biol Rep. 2012 Jan;39(1):369-73. Epub 2011 May 10. (并列)4. Tao J, Wu D, Li P, Xu B, Lu Q,Zhang W. microRNA-18a, a member of the oncogenic miR‑17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells. Mol Med Report. 2012 Jan;5(1):167-72.5. Tao J, Lu Q, Wu D, Li P, Xu B, Qing W, Wang M, Zhang Z, Zhang W. microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol Rep. 2011 Jun;25(6):1721-9.6. Wu D, Tao J, Xu B, Qing W, Li P, Lu Q and Zhang W. Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells. Urol Int. 2011;87(1):105-13. Epub 2011 May 18.7. Deyao Wu, Jun Tao, Bin Xu, Pengchao Li, Qiang Lu, Wei Zhang. Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer. Mol Med Report. 2012 Mar;5(3):695-9. doi: 10.3892/mmr.2011.711. Epub 2011 Dec 14.8. Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate. 2010 Apr 1;70(5):467-72.9. Xu B, Li JM, Tong N, Tao J, Li PC, Song NH, Zhang W, Wu HF, Feng NH and Hua LX. VEGFA +936C>T polymorphism and cancer risk: a meta-ysis. Cancer Genet Cytogenet. 2010 Apr 1;198(1):7-14.10. Xu B, Mi YY, Min ZC, Cheng G, Tong N, Tao J, Li PC, Wang ML, Tang JL, Zhang ZD et al. p53 codon 72 increased biochemical recurrence risk after radical prostatectomy in a southern Chinese population. Urol Int. 2010;85(4):401-5. Epub 2010 Jul 20.11. Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N et al. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem. 2011 Apr;350(1-2):207-13.12. Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, Min ZC, Tao J, Li PC, Zhang W et al. IL-6 -174G>C polymorphism and cancer risk: a meta-ysis involving 29,377 cases and 37,739 controls. Mol Biol Rep. 2011 Apr;38(4):2589-96. Epub 2010 Nov 23.13. Xu B, Wang J, Tong N, Mi Y, Min Z, Tao J, Li P, Cheng G, Li J, Wang M et al. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression. Prostate. 2010 Jul 1;70(10):1146-52.14. Xu B, Xu Z, Cheng G, Min ZC, Mi Y, Zhang ZZ, Tao J, Li PC, Wang ML, Tang JL et al. Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese. Cancer Genet Cytogenet. 2010 Oct 15;202(2):76-81.15. 超, 陶俊, 呂強(qiáng), 吳德堯, 秦偉杰, 張煒.MiR-143在膀胱移行細(xì)胞癌中的表達(dá)和功能. 南京醫(yī)科大學(xué)學(xué)報(bào),2010.09;30(9): 1235-123916.超, 陶俊,呂強(qiáng),吳德堯,秦偉杰,張煒 MiR-200c和miR-141在膀胱移行細(xì)胞癌中的表達(dá)研究南京醫(yī)科大學(xué)學(xué)報(bào).2010,06;30(6):768-78617. 超,宋日進(jìn),孟小鑫,呂強(qiáng),張煒,殷長(zhǎng)軍,李杰 P雙頻雙導(dǎo)管超聲碎石系統(tǒng)治療腎結(jié)石分析. 臨床泌尿,2012.01, 27(1): 46-48,5118. 超,秦超,王增軍,張煒,李杰 , 國(guó)產(chǎn)三件套可膨脹型假體植入治療勃起功能障礙. 南京醫(yī)科大學(xué)學(xué)報(bào), 2012.01, 32(1): 150-152
-

- 顧民主任醫(yī)師,教授,中華醫(yī)學(xué)會(huì)男科學(xué)會(huì)委員
查看醫(yī)生信息
擅長(zhǎng):血尿,腎結(jié)石
-

- 張煒(?。?/a>主任醫(yī)師,副教授,省級(jí)科技進(jìn)步
查看醫(yī)生信息
擅長(zhǎng):
-

- 宋日進(jìn)
查看醫(yī)生信息
擅長(zhǎng):
-

- 劉豪
查看醫(yī)生信息
擅長(zhǎng):
-

- 河西泌尿科門(mén)診普通門(mén)診
查看醫(yī)生信息
擅長(zhǎng):
-

- 張煒主任醫(yī)師,教授,省級(jí)科技進(jìn)步,中華醫(yī)學(xué)會(huì)泌尿外科學(xué)分會(huì)委員
查看醫(yī)生信息
擅長(zhǎng):
-

- 張煒(大)主任醫(yī)師,教授,省級(jí)科技進(jìn)步
查看醫(yī)生信息
擅長(zhǎng):腎癌,尿毒癥,前列腺癌
-

- 殷長(zhǎng)軍主任醫(yī)師,教授,中華醫(yī)學(xué)科技獎(jiǎng)
查看醫(yī)生信息
擅長(zhǎng):前列腺癌,腎腫瘤,腺性膀胱炎,膀胱癌,腎上腺腫瘤,膀胱腫瘤,腎透明細(xì)胞癌,腎病
